Gene discovery was greatly facilitated by a new
exome sequencing technology, which analyzes all protein - coding regions of the genome at once.
Not exact matches
Using a novel combination of
technologies, including trio
exome sequencing of patient / parental DNA and genetic studies in the tiny larvae of zebrafish, the EuroEPINOMICS RES consortium found that mutations in the gene CHD2 are responsible for a subset of epilepsy patients with symptoms similar to Dravet syndrome — a severe form of childhood epilepsy that is in many patients resistant to currently available anti-epileptic drugs.
Using
technologies like whole genome or whole
exome (the protein - coding portion of the genome)
sequencing requires specialized equipment and advanced data analysis and is still relatively expensive.
The advent of accessible and relatively inexpensive high - throughput
sequencing technology has resulted in extensive
sequencing of whole human genomes or
exomes in a research setting and seems likely to lead to an explosion of genomic
sequencing in a clinical context.
Considerations of privacy and autonomy are being challenged on a massive scale by WGS and whole -
exome sequencing (WES),
technologies that are expected to contribute to our understanding of host genomics in the context of infectious disease.
A relatively new
technology called
exome sequencing has identified a few families with novel mutations in their HD genes.
These
technologies include next generation
exome and whole - genome
sequencing, ChiP -
sequencing, tissue transcriptome and epitope profiling, and miRNome, proteome and metabolome screening in different body fluids.
Follow - up of these studies, including work on long and short non-coding RNA and whole -
exome sequencing, are performed using next - generation
sequencing technology.
PHG Foundation has previously carried out work examining the implications of whole
exome and genome
sequencing on clinical services which identified data sharing as a key priority for these
technologies to be deployed effectively for clinical benefit.
With this
technology, we
sequence DNA, RNA, micro-RNAs and perform ChIP - Seq and whole
exome sequencing.
As part of their
technology development goals, the scientists will also work to further improve
sequence quality — decoding
exomes and genomes as accurately and as cheaply as possible.
In the last five years, major advances in genomic
technology, especially in
sequencing whole genomes and whole
exomes (the portion of the genome that codes for proteins), have given rare disease research an important boost.
In this study we aim to identify new genetic causes of PCG and JOAG using the newest genetic
technologies (
exome sequencing) in families, and to evaluate the role of such new genes in POAG patients.
Under Dr. Mullikin's leadership, NISC has begun to apply genome
sequencing technologies to clinical research, especially with its largest project, called ClinSeq, for which NISC has generated more than 500 whole -
exome sequences to date.
The lab
sequences whole genomes, whole
exomes and targeted regions of the genome with ultrahigh - throughput DNA
sequencing technologies to identify DNA
sequence variants relevant to clinical and basic biological problems.
Here, we demonstrate the PhenomeNET Variant Predictor (PVP) system that exploits semantic
technologies and automated reasoning over genotype - phenotype relations to filter and prioritize variants in whole
exome and whole genome
sequencing datasets.
Researchers studying Mendelian and other genetic disorders in mice have new techniques and
technologies to create new mouse models; paired with whole -
exome sequencing, they have increased the rate of mutation discovery and validation tenfold.